Differentially expressed proteins in nitric oxide-stimulated NIH/3T3 fibroblasts: Implications for inhibiting cancer development

Yonsei Medical Journal

Volumn 56, Issue 2, 2015, Pages 563-571

  Shim, Dong Hwi ^a   Lim, Joo Weon ^b   Kim, Hyeyoung ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cancer; NIH 3T3 cells; Nitric oxide; Proteomic analysis

Indexed keywords

26S PROTEASOME ASSOCIATED PAD1 HOMOLOG; 3, 3 BIS (2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CALRETICULIN; CHAPERONIN CONTAINING TCP1; CYTOKERATIN 19; DIMETHYLARGININASE; END BINDING FAMILY MEMBER 1; F ACTIN CAPPING PROTEIN; GLUCOSIDASE; GLUCOSIDASE II; HEAT SHOCK 70 RELATED PROTEIN ALBINO; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; LAMIN B1; NITRIC OXIDE; NUCLEOPHOSMIN; OXYGEN REGULATED PROTEIN PRECURSOR; PEPTIDES AND PROTEINS; TROPOMYOSIN 3; UBIQUITOUS TROPOMODULIN; UNCLASSIFIED DRUG; VINCULIN; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; OXYGEN-REGULATED PROTEINS; PROTEIN;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FINGERPRINTING; FIBROBLAST; ISOELECTRIC FOCUSING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL ELECTROPHORESIS; 3T3 CELL LINE; ANIMAL; HUMAN; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; PROCEDURES; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBROBLASTS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; NEOPLASMS; NIH 3T3 CELLS; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84922783588     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2015.56.2.563     Document Type: Article

References (46)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-142.
2. Beck KF, Eberhardt W, Frank S, Huwiler A, Messmer UK, Mühl H, et al. Inducible NO synthase: role in cellular signalling. J Exp Biol 1999;202(Pt 6):645-653.
3. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991;289:130-136.
4. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005;15:277-289.
5. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007; 67:1407-1410.
6. Sugita H, Kaneki M, Furuhashi S, Hirota M, Takamori H, Baba H. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein. Mol Cancer Res 2010;8:1152-1163.
7. Carneiro ZA, Biazzotto JC, Alexiou AD, Nikolaou S. Nitric oxide photorelease from a trinuclear ruthenium nitrosyl complex and its in vitro cytotoxicity against melanoma cells. J Inorg Biochem 2014;134:36-38.
8. Brantley EC, Guo L, Zhang C, Lin Q, Yokoi K, Langley RR, et al. Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl Oncol 2010;3:380-388.
9. Patel HJ, Belvisi MG, Donnelly LE, Yacoub MH, Chung KF, Mitchell JA. Constitutive expressions of type I NOS in human airway smooth muscle cells: evidence for an antiproliferative role. FASEB J 1999;13:1810-1816.
10. Seo JY, Yu JH, Lim JW, Mukaida N, Kim H. Nitric oxide-induced IL-8 expression is mediated by NF-kappaB and AP-1 in gastric epithelial AGS cells. J Physiol Pharmacol 2009;60 Suppl 7:101-106.
11. Lim JW, Kim H, Kim KH. NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection. Free Radic Biol Med 2001;31:355-366.
12. Davies CM, Guilak F, Weinberg JB, Fermor B. Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage 2008;16:624-630.
13. Yu JH, Yun SY, Lim JW, Kim H, Kim KH. Proteome analysis of rat pancreatic acinar cells: implication for cerulein-induced acute pancreatitis. Proteomics 2003;3:2446-2453.
14. Faure O, Graff-Dubois S, Bretaudeau L, Derré L, Gross DA, Alves PM, et al. Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes. Int J Cancer 2004;108:863-870.
15. Gabai VL, Yaglom JA, Waldman T, Sherman MY. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 2009;29:559-569.
16. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. A mitochondrial specific stress response in mammalian cells. EMBO J 2002;21:4411-4419.
17. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 2008;283: 2031-2041.
18. Miyata Y, Nakamoto H, Neckers L. The therapeutic target Hsp90 and cancer hallmarks. Curr Pharm Des 2013;19:347-365.
19. Ma L, Sato F, Sato R, Matsubara T, Hirai K, Yamasaki M, et al. Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer. Oncol Rep 2014;31:2482-2492.
20. Guttmann DM, Koumenis C. The heat shock proteins as targets for radiosensitization and chemosensitization in cancer. Cancer Biol Ther 2011;12:1023-1031.
21. Michalak M, Robert Parker JM, Opas M. Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 2002;32:269-278.
22. Hisaoka M, Matsuyama A, Nakamoto M. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma. Am J Pathol 2012;180:2076-2083.
23. Pfister AS, Hadjihannas MV, Röhrig W, Schambony A, Behrens J. Amer2 protein interacts with EB1 protein and adenomatous polyposis coli (APC) and controls microtubule stability and cell migration. J Biol Chem 2012;287:35333-35340.
24. Tamura N, Draviam VM. Microtubule plus-ends within a mitotic cell are ‘moving platforms’ with anchoring, signalling and force-coupling roles. Open Biol 2012;2:120132.
25. Morrison EE. The APC-EB1 interaction. Adv Exp Med Biol 2009;656:41-50.
26. Kim MJ, Yun HS, Hong EH, Lee SJ, Baek JH, Lee CW, et al. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction. Cancer Lett 2013; 339:15-24.
27. Sun S, Xu MZ, Poon RT, Day PJ, Luk JM. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res 2010;9:70-78.
28. Li L, Du Y, Kong X, Li Z, Jia Z, Cui J, et al. Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Clin Cancer Res 2013;19:4651-4661.
29. Suradej B, Pata S, Kasinrerk W, Cressey R. Glucosidase II exhibits similarity to the p53 tumor suppressor in regards to structure and behavior in response to stress signals: a potential novel cancer biomarker. Oncol Rep 2013;30:2511-2519.
30. Wong JC, Hasan MR, Rahman M, Yu AC, Chan SK, Schaeffer DF, et al. Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence. Int J Cancer 2013;133:1567-1577.
31. Deng WH, Chen C, Wang WX, Yu J, Li JY, Liu L. Effects of ORP150 on appearance and function of pancreatic beta cells following acute necrotizing pancreatitis. Pathol Res Pract 2011;207: 370-376.
32. Li C, Liu D, Yuan Y, Huang S, Shi M, Tao K, et al. Overexpression of Apg-2 increases cell proliferation and protects from oxidative damage in BaF3-BCR/ABL cells. Int J Oncol 2010;36:899-904.
33. Gotoh K, Nonoguchi K, Higashitsuji H, Kaneko Y, Sakurai T, Sumitomo Y, et al. Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomas. FEBS Lett 2004;560:19-24.
34. Carisey A, Ballestrem C. Vinculin, an adapter protein in control of cell adhesion signalling. Eur J Cell Biol 2011;90:157-163.
35. Goldmann WH, Auernheimer V, Thievessen I, Fabry B. Vinculin, cell mechanics and tumour cell invasion. Cell Biol Int 2013;37: 397-405.
36. Kostyukova AS. Tropomodulins and tropomodulin/tropomyosin interactions. Cell Mol Life Sci 2008;65:563-9.
37. Franzén B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 1996;73:909-913.
38. Zheng Q, Safina A, Bakin AV. Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility. Int J Cancer 2008;122:78-90.
39. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, Lee CW. Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med 2006;38:455-465.
40. Lee YJ, Jeong SH, Hong SC, Cho BI, Ha WS, Park ST, et al. Prognostic value of CAPZA1 overexpression in gastric cancer. Int J Oncol 2013;42:1569-1577.
41. Schoenfeld A, Luqmani Y, Sinnett HD, Shousha S, Coombes RC. Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 1996;74:1639-1642.
42. Ju JH, Yang W, Lee KM, Oh S, Nam K, Shim S, et al. Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells. Clin Cancer Res 2013;19:4335-4346.
43. Guenther MG, Yu J, Kao GD, Yen TJ, Lazar MA. Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev 2002;16:3130-5.
44. Nikawa J, Kimura M. A novel function of the human chaperonin CCT epsilon subunit in yeast. Biosci Biotechnol Biochem 2012; 76:199-201.
45. Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, et al. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer 2014; 14:152.
46. Boult JK, Walker-Samuel S, Jamin Y, Leiper JM, Whitley GS, Robinson SP. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. J Pathol 2011;225:344-352.